BIOCON.BO - Biocon Limited

BSE - BSE Real Time Price. Currency in INR

Biocon Limited

20th KM, Hosur Road
Electronics City
Bengaluru 560100
India
91 80 2808 2808
http://www.biocon.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Ms. Kiran Mazumdar-ShawFounder, Chairman and Managing Director20.41MN/A1953
Dr. Arun Suresh Chandavarkar B.Tech., M.S., Ph.D.(Chem Eng)CEO, Joint MD & Exec. Director33MN/A1961
Mr. Siddharth Mittal BCom, CA, CPAPres of Fin. & CFON/AN/A1978
Mr. Paul Vazhayil Thomas BS, MBAVP & Head of Biosimilars - MAbsN/AN/A1973
Mr. Suresh SubramanianSr. VP & Head of Branded Formulations Bus. - IndiaN/AN/A1963
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Biocon Limited, a biopharmaceutical company, develops, manufactures, and sells biopharmaceuticals for diabetes, cancer, and autoimmune conditions. The company operates through Small Molecule APIs & Generic Formulations, Biologics, Branded Formulations, and Research Services segments. It offers active pharmaceutical ingredients, including cardiovascular agents, anti-obesity agents, immunosuppressants, narrow spectrum antibiotics, and antifungals; and branded formulations in the areas of metabolics, oncology, immunology, and auto immune indications. The company also provides biosimilars comprising recombinant human insulin, insulin glargine, insulin lispro, insulin aspart, and monoclonal antibodies and other biologics; Nimotuzumab, a biologic for head and neck cancer under the IOMAb EGFR name; and ALZUMAb, an itolizumab for the treatment of psoriasis. In addition, it offers branded formulations for various chronic therapeutic areas, such as metabolics, oncotherapeutics, immunotherapy, nephrology, virology, and specialty. The company's principal brands include INSUGEN, BASALOG, CANMAb, EVERTO, and Nufil. Further, it operates as a contract research organization that provides a suite of integrated drug discovery and development services for start-up companies, pharmaceuticals/biotech, agrochemical, chemical, and nutrition and animal health companies. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.

Corporate Governance

Biocon Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.